Skip to main content
Top

Supportive Care in Cancer

Issue 10/2006

Content (14 Articles)

Supportive Care International

Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital

Camilla Zimmermann, Dori Seccareccia, Allyson Clarke, David Warr, Gary Rodin

Special Article

The clinical significance of quality of life assessments in oncology: a summary for clinicians

Jeff A. Sloan, Marlene H. Frost, Rick Berzon, Amylou Dueck, Gordon Guyatt, Carol Moinpour, Mirjam Sprangers, Carol Ferrans, David Cella

Review Article

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review

Catherine A. Hauser, Martin R. Stockler, Martin H. N. Tattersall

Original Article

Physical activity and quality of life in head and neck cancer survivors

Laura Q. Rogers, Kerry S. Courneya, K. Thomas Robbins, James Malone, Alison Seiz, Lori Koch, Krishna Rao, Meenakshi Nagarkar

Original Article

A comparative study of living conditions in cancer patients who have returned to work after curative treatment

Sævar B. Gudbergsson, Sophie D. Fosså, Elling Borgeraas, Alv A. Dahl

Original Article

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer

Philippe Fagnoni, Samuel Limat, Loïc Chaigneau, Emmanuel Guardiola, Stéphanie Briaud, Bernard Schmitt, Yacine Merrouche, Xavier Pivot, Marie-Christine Woronoff-Lemsi

Original Paper

Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality

Jane M. Geraci, Walter Tsang, Rosalie V. Valdres, Carmen P. Escalante

Original Article

Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases

Jacqueline Sze, Stephen Marisette, Diane Williams, Joyce Nyhof-Young, Dauna Crooks, Amna Husain, Andrea Bezjak, Rebecca K. S. Wong

Letter to the Editor

Letter to the Editor

Friedrich Stiefel

Forthcoming Meetings

Forthcoming meetings

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine